Additional early-stage research and drug discovery news in brief, from: Asher.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abiomed, Cellibre, Codex DNA, Concept Medical, Perkinelmer, T2 Biosystems, Telesis Bio.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altamira, Kite, Novocure, Refuge, Zilentin.

Additional early-stage research and drug discovery news in brief, from: Kancera.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cerba, Day Zero, Femasys, Fineheart, GE, Taliaz.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, C4X, Chemocentryx, Currax, Dr. Falk, Erasca, Hitgen, HK Inno.N, ICER, Lupin, Nora, Novo Nordisk, Pfizer, Polypid, Scynexis, Sebela, Sumitomo, Sunovion, Sunshine, Takeda, Trethera, Vivasc, Vivus and Zedira.

Additional early-stage research and drug discovery news in brief, from: Enanta, Hemostemix, Iecure, Inmune, Kalvista, Surface Oncology, Precerv, Qualigen.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: AMC Health, Bioskryb, Cooper Genomics, GE, Genoscreen, Heart Test Laboratories, Heartsciences, Icecure Medical, Illumina, Nanovibronix, Olleyes, Pronia Medical Systems, Revamp Medical, Rosies Base, Spinecraft, Tobii, Transformativemed, Virinx.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Alvotech, Ambrx, Ayala, Clarus, Insmed, FDA, Galecto, ITM, Jamp, Kamada, Kintara, Nanobiotix, Shionogi, Tolmar.

Additional early stage research and drug discovery news in brief, from: Iterion Therapeutics.